CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $862.95M, above the global median of $520.53M
- FinancialsAltman Z-Score 2.37: grey zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.04%Above 5Y avg (1.73%)
Annual Rate
CNY 0.18Paid annual
Payout Ratio
200.0%High
Payback Period
47.4 yr
Last Ex-Dividend
Jul 30, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
6.67BCNY991.74M · vs all stocks (USD)
Trailing P/E
59.13xRevenue (TTM)
5.80BCNY862.95M · vs all stocks (USD)
Profit Margin
2.03%Beta
-0.1500xvs all stocks
52-Week Change
-38.78%vs all stocks
Market Capitalization
6.67BCNY991.74M · vs all stocks (USD)
Enterprise Value
8.11BCNY1.21B · vs all stocks (USD)
Trailing P/E
59.13xForward P/E
6.43xPEG Ratio
-0.2289xPrice to Sales (TTM)
1.16xPrice to Book (MRQ)
1.29xEnterprise to Revenue
1.40xEnterprise to EBITDA
90.25xGross Margin
22.57%Profit Margin
2.03%Operating Margin
-20.48%Return on Assets (TTM)
-0.34%Return on Equity (TTM)
2.35%Revenue (TTM)
5.80BCNY862.95M · vs all stocks (USD)
Revenue per Share (TTM)
7.65CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-48.00%Gross Profit (TTM)
2.11BCNY313.38M · vs all stocks (USD)
EBITDA (TTM)
662.21MCNY98.48M · vs all stocks (USD)
Net Income (TTM)
117.67MCNY17.50M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-48.01%Operating Cash Flow (TTM)
-185.01MCNY-27.51M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-855.46MCNY-127.21M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1800CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
2.04%vs all stocks
5-Year Average Dividend Yield
1.73%vs all stocks
Payout Ratio
200.00%Minority Interest (Equity)
1.58BCNYFY2025 · Dec 31, 2025Revenue
6.58BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
4.04BCNYFY2025 · Dec 31, 2025Gross Profit
2.53BCNYFY2025 · Dec 31, 2025Operating Income
375.21MCNY55.80M · vs all stocks (USD)
Pre-tax Income
473.56MCNYFY2025 · Dec 31, 2025Income Tax Expense
54.50MCNYFY2025 · Dec 31, 2025Net Income
419.05MCNYFY2025 · Dec 31, 2025EBIT
524.15MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
662.21MCNYFY2025 · Dec 31, 2025Research & Development
102.55MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.41BCNYFY2025 · Dec 31, 2025Other Operating Expenses
60.46MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
10.00MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
50.59MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
760.74MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
760.74MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
419.05MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-69.11MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
1.01BCNYFY2025 · Dec 31, 2025Free Cash Flow
926.18MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.13BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
419.05MCNYFY2025 · Dec 31, 2025Other Non-cash Items
58.81MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
345.14MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
191.94MCNYFY2025 · Dec 31, 2025Capital Expenditures
-88.78MCNYFY2025 · Dec 31, 2025Net Acquisitions
4.10MCNYFY2025 · Dec 31, 2025Purchase of Investments
-5.89BCNYFY2025 · Dec 31, 2025Sale of Investments
5.34BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-637.00MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.74BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-853.06MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-280.06MCNYFY2025 · Dec 31, 2025Other Financing Charges
-1.26BCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-654.64MCNYFY2025 · Dec 31, 2025Shares Outstanding
756.98MSharesUpdated Aug 20, 2026Float Shares
470.38MSharesUpdated Aug 20, 2026% Held by Insiders
39.52%vs all stocks
% Held by Institutions
5.18%vs all stocks
Total Cash (MRQ)
1.62BCNY241.54M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.15CNYUpdated Aug 20, 2026Total Debt (MRQ)
1.62BCNY240.25M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2377xCurrent Ratio (MRQ)
2.09xBook Value per Share (MRQ)
6.90CNYUpdated Aug 20, 2026Total Assets
11.77BCNY1.75B · vs all stocks (USD)
Total Current Assets
7.72BCNYFY2025 · Dec 31, 2025Total Liabilities
4.83BCNYFY2025 · Dec 31, 2025Total Non-current Assets
4.05BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.01BCNYFY2025 · Dec 31, 2025Total Current Liabilities
3.83BCNYFY2025 · Dec 31, 2025Cash
1.13BCNYFY2025 · Dec 31, 2025Cash Equivalents
103.56MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.23BCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.11BCNYFY2025 · Dec 31, 2025Accounts Receivable
3.36BCNYFY2025 · Dec 31, 2025Inventory
1.38BCNYFY2025 · Dec 31, 2025Accounts Payable
876.24MCNYFY2025 · Dec 31, 2025Short-term Debt
948.59MCNYFY2025 · Dec 31, 2025Other Current Liabilities
173.80MCNYFY2025 · Dec 31, 2025Long-term Debt
736.66MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
3.81MCNYFY2025 · Dec 31, 2025Common Stock (Book)
756.98MCNYFY2025 · Dec 31, 2025Retained Earnings
3.73BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
6.94BCNY1.03B · vs all stocks (USD)
52-Week Low
7.45CNYUpdated Aug 20, 202652-Week High
14.98CNYUpdated Aug 20, 202652-Week Change
-38.78%vs all stocks
Beta
-0.1500xvs all stocks
50-Day MA
8.63CNYUpdated Aug 20, 2026200-Day MA
10.90CNYUpdated Aug 20, 2026Avg 10-Day Volume
15.98MSharesUpdated Aug 20, 2026Avg 30-Day Volume
15.16MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.1500CNYUpdated Aug 20, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
Where is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 17,499,381.438Operating Cash Flow (USD, TTM): -27,512,280.33
Financial Health
Altman Z-Score 2.37: grey zoneSignificant
Altman Z-Score: 2.37
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $862.95M, above the global median of $520.53MNotable
Revenue (USD): 862,952,299.822Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Janux Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Novogene Co., Ltd.
Tier 1ProductionApproval-Gated PipelineSenseMakingFlow
Olema Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Vor Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Cisen Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Chongqing Pharscin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Pacira BioSciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hunan Er-Kang Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Guangyuyuan Chinese Herbal Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Bide Pharmatech Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Bright Horizons Family Solutions Inc.
3 interpretationsReceivables Heavy and GrowingDrawdown With FCF And Cash BackingClose Below 40W SMA With Profitability
JSL S.A.
3 interpretationsReceivables Heavy and GrowingDrawdown With FCF And Cash BackingClose Below 40W SMA With Profitability
Banco Hipotecario S.A.
2 interpretationsDrawdown With FCF And Cash BackingClose Below 40W SMA With Profitability